Skip to main content
SpringerLink
Log in

Steroid-induced side-effects of oral contraceptives

  • Chapter
Future Aspects in Contraception

  • 69 Accesses

Abstract

This chapter summarizes not all the reported but the main clinically relevant side-effects of combined pills and sequential preparations. Many of them may also be observed with contraceptives containing only an oestrogen (morning-after pill) or a progestogen (minipill, post-coital pill); however, experience is not sufficient to document all side-effects of mono-preparations satisfactorily. Extensive documentation of the data presented can be found in detailed publications1–21 and in the references quoted in the text.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Astedt, B. (1982). Oral contraception and some debatable side effects. Acta Obstet. Gynec. Scand, 105 (Suppl.), 17

    Google Scholar 

  2. Blaskova, O., Sasko, A., Pontuch, A., Veselska, T., Lipovska, A. and Kostolny, 1. (1981). Vedlajsie ucinky peroralnych antikonceptiv (Side effects of oral contraceptives). Bratisl. Lek. Listy, 75, 167

    PubMed  CAS  Google Scholar 

  3. Braendli, B. and Filippini, L. (1979). Gastroenterologische Nebenwirkungen oraler hormoneller Antikonzeptiva. Med. Klin, 74, 425

    PubMed  CAS  Google Scholar 

  4. Cullberg, G., Samsioe, G., Andersen, R. F., Bredesgaard, P., Andersen, N. B., Ernerot, H., Fandee, E., Fylling, P., Haach-Sorensen, P. E., Klottrup, P., Pedersen, J. H. and Sandager, T. (1982). Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination. Contraception, 26, 229

    Article  PubMed  CAS  Google Scholar 

  5. Dalen, J. E. and Hickler, R. B. (1981). Oral contraceptives and cardiovascular disease. Am. Heart J, 101, 626

    Article  PubMed  CAS  Google Scholar 

  6. Geyer, N. (1980). Neurologische and psychiatrische Symptome bei der Einnahme von Ovulationshemmern. Therapiewoche, 30, 4828

    Google Scholar 

  7. Giedl, J. and Gebhardt, Ch. (1981). Kontrazeptiva and gutartige Lebertumoren. Fortschr. Med, 99, 163

    Google Scholar 

  8. Kaiser, R. (1983). Nutzen and Risiken der hormonalen Kontrazeption. Dtsch. Apoth. Ztg, 123, 91

    Google Scholar 

  9. Keep, P. A. van and Kopera, H. (eds.) (1983) Oral Contraceptives and Lipoproteins. Work-shop Conference, International Health Foundation, Hawaii

    Google Scholar 

  10. Kopera, H. (1976). Orale Kontrazeptiva. Wien. Klin. Wochenschr, 88, 717

    PubMed  CAS  Google Scholar 

  11. Ludwig, H. (1981). Nebenwirkungen der hormonalen Kontrazeption: Einfluß auf Gefäßsystem and Blutgerinnung, metabolische Wirkungen and Fettstoffwechsel. Praxis, 70, 549

    PubMed  CAS  Google Scholar 

  12. Mall-Haefeli, M. (ed.) (1982). Wirkung Kontrazeptiver Steroide

    Google Scholar 

  13. Mammen, E. F. (1982). Oral contraceptives and blood coagulation: a critical review. Am. J. Obstet. Gynec, 142, 781

    PubMed  CAS  Google Scholar 

  14. Rabe, T. and Runnebaum, B. (1982). Kontrazeption. Methoden, Indikation, Kontraindikation. (Berlin, Heidelberg, New York: Springer-Verlag )

    Google Scholar 

  15. Royal College of General Practitioners (1983). Incidence of arterial disease among oral contraceptive users; oral contraception study. J. Coll. Gen. Pract, 33, 75

    Google Scholar 

  16. Stadel, B. V. (1981). Oral contraceptives and cardiovascular disease. N. Engl. J. Med, 305, 612

    Article  PubMed  CAS  Google Scholar 

  17. Stadel, B. V. (1981). Oral contraceptives and cardiovascular disease. N. Engl. J. Med, 305, 672

    Article  PubMed  CAS  Google Scholar 

  18. Stockley, I. (1976). Interactions with oral contraceptives. Pharm. J, 216, 140

    CAS  Google Scholar 

  19. Taubert, H.-D. and Kuhl, H. (1981) Kontrazeption mit Hormonen. Ein Leitfaden für die Praxis. ( Stuttgart: Thierne )

    Google Scholar 

  20. Wynn, V. (1975). Vitamins and oral contraceptive use. Lancet, 1, 561

    Article  PubMed  CAS  Google Scholar 

  21. Zaun, H. (1982). Hormonale Kontrazeption — unerwünschte Begleiterscheinungen an Haut and Haaren. Therapiewoche, 32, 1299

    Google Scholar 

  22. Vandenbroucke, J. P., Valkenburg, H. A., Boersma, J. W., Cats, A., Festen, J.J.M., Huber-Bruning, O. and Rasker, J. J. (1982). Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect. Lancet, 2, 839

    Article  PubMed  CAS  Google Scholar 

  23. Rubin, G. L., Ory, H. W. and Layde, P. M. (1982). Oral contraceptives and pelvic inflammatory disease. Am. J. Obstet. Gynec, 144, 630

    PubMed  CAS  Google Scholar 

  24. Kopera, H. (1984). Oestrogens and Psyche. Wien. Klin. Wochenschr, 96, 456

    PubMed  CAS  Google Scholar 

  25. Oster, P., Arab, L., Kohlmeier, M., Mordasini, R., Schellenberg, B. and Schlierf, G. (1982). Effects of estrogens and progestogens on lipid metabolism. Am. J. Obstet. Gynec, 142, 773

    PubMed  CAS  Google Scholar 

  26. Wingrave, S. T. and Kay, C. R. (1982). Oral contraceptives and gallbladder disease. Royal College of General Practitioners Oral Contraception Study. Lancet, 2, 957

    CAS  Google Scholar 

  27. Wilson, J. H. P. (1982). Oral contraceptives and hepatic tumours. Agressologie, 23, 21

    PubMed  CAS  Google Scholar 

  28. Meade, T. W. (1982). Oral contraceptives, clotting factors, and thrombosis. Am. J. Obstet. Gynec., 142, 758

    PubMed  CAS  Google Scholar 

  29. Bottiger, L. E., Boman, G., Eklund, G. and Westerholm, B. (1980). Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet, 1, 1097

    Article  PubMed  CAS  Google Scholar 

  30. Editorial (1983). Long-term oral contraceptive use and the risk of breast cancer. Oral contraceptive use and the risk of ovarian cancer. Oral contraceptive use and the risk of endometrial cancer. J. Am. Med. Assoc, 249, 1591

    Article  Google Scholar 

  31. Henderson, B. E., Casagrande, J. T., Pike, M. C., Mack, T., Rosario, I. and Duke, A. (1983). The epidemiology of endometrial cancer in young women. Br. J. Cancer, 47, 749

    Article  PubMed  CAS  Google Scholar 

  32. Hulka, B. S., Chambless, L. E., Kaufman, D. G., Fowler, W. C. and Greenberg, B. G. (1982). Protection against endometrial carcinoma by combination-product oral contraceptives. J. Am. Med. Assoc, 247, 475

    Article  CAS  Google Scholar 

  33. Cramer, D. W., Hutchinson, G. B., Welch, W. R., Scully, R. E. and Knapp, R. C. (1982). Factors affecting the association of oral contraceptives and ovarian cancer. N. Engl. J. Med, 307, 1047

    Article  PubMed  CAS  Google Scholar 

  34. A Rosenherg; L:; shapiro; S; Stone, D:; Kaufman, D. W., Helmrich, 91, Mieitinen, (3.9., Stolley, P. D., Rosenhein, N. B., Schottenfeld, D. and Engle, R. L. Jr. (1982). Epithelial ovarian cancer and combination oral contraceptives. J. Am. Med. Assoc, 247, 3210

    Google Scholar 

  35. Lauritzen, Ch. (1978). Sekundare Amenorrhoe nach hormonalen Kontrazeptiva. Med. Klin, 73, 1343

    PubMed  CAS  Google Scholar 

  36. Spellacy, W.N. (1982). Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives. Am. J. Obstet. Gynec, 142, 732

    PubMed  CAS  Google Scholar 

  37. Radberg, T., Gustafson, A., Skryten, A. and Karlsson, K. (1981). Oral contraception in diabetic women. Diabetes control, serum and high density lipoprotein lipids during low-dose progestogen, combined oestrogen/progestogen and nonhormonal contraception. Acta Endocrinol, 98, 246

    PubMed  CAS  Google Scholar 

  38. Briggs, M.H. and Briggs, M. (1982). Randomized prospective studies on metabolic effects of oral contraceptives. Acta Obstet. Gynec. Scand 105 (Suppl.), 25

    Google Scholar 

  39. Castelli, W. P., Kannel, W. B., Garrison, R. L., Feinleib, M. and McNamara, P. M. (1977). Blood lipoproteins in oral contraceptive users: The Framingham Study. Circulation, 3 (Suppl.), 44

    Google Scholar 

  40. Demacker, P. N. M., Schade, R. W. B., Stalenhoef, A. F. H., Stuyt, P. M. J. and Laar, A. van’t (1982). Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations. Br. Med. J, 284, 1213

    Article  CAS  Google Scholar 

  41. Knopp, R. H., Walden, C. E., Wahl, P. W. and Hoover, J. J. (1982). Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency. Am. J. Obstet. Gynec, 142, 725

    PubMed  CAS  Google Scholar 

  42. Wynn, V. and Niththyananthan, R. (1982). The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Am. J. Obstet. Gynec, 142, 766

    PubMed  CAS  Google Scholar 

  43. Lees, R. S. and Lees, A. M. (1982). High-density lipoproteins and the risk of atherosclerosis. N. Engl. J. Med, 306, 1346

    Article  Google Scholar 

  44. Cerskus, I., Hedlin, A., Powell, M., Chuchryk, J., Kakis, G. and Chow, A. (1982). Effects of oral contraceptives on lipid lipoprotein profile. Clin. Pharmacol. Ther, 31, 209

    Google Scholar 

  45. Gaspard, U. J., Romus, M. A., Gillain, D., Duvivier, J., Demey-Ponsart, E. and Franchimont, P. (1983). Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Contraception, 27, 577

    Article  PubMed  CAS  Google Scholar 

  46. Havekes, L., Gent, C. M., van Stegerhoek, C. I., Arntzenius, A. C. and Hessel, L. W. (1981). High density lipoprotein cholesterol and apolipoprotein A-1 levels in 32-33-year old women on steroid contraceptives-differences between two frequently used low-estrogen pills. Clin. Chim. Acta, 116, 223

    Article  PubMed  CAS  Google Scholar 

  47. Kannel, W. B. (1977). Cardiovascular hazards of oral contraceptive use. J. Am. Med. Assoc, 237, 2530

    Article  CAS  Google Scholar 

  48. Kay, C. R. (1982). Progestogens and arterial disease-evidence from the Royal College of General Practitioners study. Am. J. Obstet. Gynec, 142, 762

    PubMed  CAS  Google Scholar 

  49. Larsson-Cohn, Z., Fahraeus, L., Wallentin, L. and Zador, G. (1982). Effects of the estrogenicity of levonorgestrel/ethinylestradiol combinations on the lipoprotein status. Acta Obstet. Gynec. Scand, 105 (Suppl.), 37

    Google Scholar 

  50. Mendoza, S. G., Kashyap, M. L., Echeverria, Y. and Zerpa, A. (1981). Plasma lipids and lipoprotein lipase activating property in women on three different combinations of estrogens and progestins. Biochem. Med, 25, 283

    Article  PubMed  CAS  Google Scholar 

  51. Samsioe, G. (1982). Study on effect of 30 mcg ethinylestradiol (EE) + 150 mcg desogestrel on lipid and lipoprotein metabolism in healthy volunteers, also in comparison with 30 mcg EE + 150 mcg levonorgestrel. Acta Obstet. Gynec. Scand, 111 (Suppl.), 55

    Google Scholar 

  52. Wahl, P., Walden, C., Knopp, R., Hoover, J., Wallace, R., Heiss G. and Rifkind, B. (1983). Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N. Engl. J. Med, 308, 862

    Article  PubMed  CAS  Google Scholar 

  53. Khaw, K. and Peart, W. S. (1982). Blood pressure and contraceptive use. Br. Med. J, 285, 403

    Article  CAS  Google Scholar 

  54. Meade, T. W. (1982). Effects of progestogens on the cardiovascular system. Am. J. Obstet. Gynec, 142, 776

    PubMed  CAS  Google Scholar 

  55. Weir, R. J. (1982) Effect on blood pressure of changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension. Scott. Med. J, 27, 212

    PubMed  CAS  Google Scholar 

  56. Penttila, I. M., Bergink, E. W., Holma, P., Hulkko, S., Makkonen, M., Pyorala, T. and Castren, O. (1983). Serum lipids and proteins during treatment with a new oral contraceptive combination containing desogestrel. Eur. J. Obstet. Gynec. Reprod. Biol, 16, 275

    Article  CAS  Google Scholar 

  57. Bergink, E. W., Bos, E. S., Kloosterboer, H. J., Lund, L., Nummi, S. and van der Vies, J. (1983). Comparison of the metabolic effects of desogestrel and of levonorgestrel in low-dose oestrogen oral contraceptives. In Keep, P.A. van and Kopera, H. (eds.) Oral Contraceptives and Lipoproteins, pp. 52–63. Workshop Conference, International Health Foundation, Hawaii

    Google Scholar 

  58. Royal College of General Practitioners (1981). Further analyses of mortality in oral contraceptive users. Lancet, 1, 541

    Google Scholar 

Download references

Authors
  1. H. Kopera
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

B. Runnebaum T. Rabe L. Kiesel

Rights and permissions

Reprints and permissions

Copyright information

© 1985 MTP Press Limited

About this chapter

Cite this chapter

Kopera, H. (1985). Steroid-induced side-effects of oral contraceptives. In: Runnebaum, B., Rabe, T., Kiesel, L. (eds) Future Aspects in Contraception. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4916-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4916-4_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8678-3

  • Online ISBN: 978-94-009-4916-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation